GAUSS-3: Statin intolerance a real problem and PCSK9 inhibition with evolocumab effective
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program creditsProf. Kausik Ray
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
John Kastelein, MD, PhD